FilingReader Intelligence

Junshi Biosciences to host Q3 2025 earnings briefing

October 21, 2025 at 10:31 AM UTCBy FilingReader AI

Shanghai Junshi Biosciences Co., Ltd. announced it will host a 2025 third quarterly results briefing on October 29, 2025, from 11:00-12:00 (Wednesday). The online briefing will take place at the Shanghai Stock Exchange Roadshow Center, offering investors an opportunity to discuss the company's operating results and financial indicators for the third quarter of 2025.

Key attendees from Junshi Biosciences will include Ms. Zou Jianjun (executive director, general manager and chief executive officer), Mr. Zhang Chun (independent non-executive director), Mr. Xu Baohong (financial director), and Mr. Wang Zhengyu (secretary of the board of directors). The company will disclose its 2025 third quarterly report on the Shanghai Stock Exchange website on the same day.

Investors can submit questions in advance from October 22, 2025, until 16:00 on October 28, 2025, via the "Pre-collection of Questions" section on the SSE Roadshow Center homepage or by emailing info@junshipharma.com. The company's securities department can be reached at 021-61058800-1153 for further inquiries.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

HKEX:1877Hong Kong Exchange

News Alerts

Get instant email alerts when Junshi BIO publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →